Reaktion #2146692

ord-bed9b5606228417db00eddf1527df70f

Reaktionsgleichung

O=C(CBr)c1ccc(OC(=O)c2ccccc2)cc1
4′-benzoyloxy-2-bromoacetophenone
COc1ccc(N)nc1
2-amino-5-methoxypyridine
O=C([O-])O.[Na+]
sodium hydrogencarbonate
COc1ccc2nc(-c3ccc(OC(=O)c4ccccc4)cc3)cn2c1
2-(4′-benzoyloxyphenyl)-6-methoxyimidazo[1,2-a]pyridine
Ausbeute 70.7%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    TemperaturThe resulting solution was refluxed for 2 hours
  2. 2
    TemperaturAfter the reaction solution was cooled
  3. 3
    SonstigeThe resulting reaction mixture
  4. 4
    Temperaturwas further refluxed for 4 hours
  5. 5
    SonstigeAfter the completion of the reaction
  6. 6
    Einengenthe solvent was concentrated under reduced pressure
  7. 7
    workup.DISSOLUTIONThe resulting residue was dissolved in chloroform
  8. 8
    Waschenwashed with water
  9. 9
    TrocknenAfter the chloroform layer was dried over anhydrous sodium sulfate
  10. 10
    workup.DISTILLATIONthe solvent was distilled off
  11. 11
    SonstigeThe resulting crude product was purified by silica gel column chromatography (elution solvent: chloroform/ethyl acetate=20/1)

Vorschrift

13.33 g (corresponding to 43.68 mmol) of 4′-benzoyloxy-2-bromoacetophenone and 5.67 g (corresponding to 45.67 mmol) of 2-amino-5-methoxypyridine were dissolved in 481 mL of ethanol. The resulting solution was refluxed for 2 hours. After the reaction solution was cooled, 6.64 g (corresponding to 79.09 mmol) of sodium hydrogencarbonate was added thereto. The resulting reaction mixture was further refluxed for 4 hours. After the completion of the reaction, the solvent was concentrated under reduced pressure. The resulting residue was dissolved in chloroform and then washed with water. After the chloroform layer was dried over anhydrous sodium sulfate, the solvent was distilled off. The resulting crude product was purified by silica gel column chromatography (elution solvent: chloroform/ethyl acetate=20/1) to obtain 10.20 g (corresponding to 30.87 mmol) of 2-(4′-benzoyloxyphenyl)-6-methoxyimidazo[1,2-a]pyridine (FIG. 3, Step 5).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08277777B2uspto-grants-2012_10